Neurotrophins Market Outlook:
Neurotrophins Market size was over USD 7.77 billion in 2025 and is projected to reach USD 15.72 billion by 2035, growing at around 7.3% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of neurotrophins is evaluated at USD 8.28 billion.
The neurotrophin market is expected to grow as the aging population increases, leading to a higher prevalence of neurodegenerative diseases. This growth is driven by the demand for innovative treatments and therapies. The market is competitive, with multiple pharmaceutical and biotechnology companies striving to develop and commercialize neurotrophin-based drugs and therapies. Companies may also be working on novel drug delivery methods to enhance the effectiveness of neurotrophin treatments.
The neurotrophins market pertains to the pharmaceutical and biotechnology sector and is related to the development and distribution of neurotrophin-related products and therapies. Neurotrophins are a family of proteins that play a critical role in the growth, development, and maintenance of neurons in the nervous system. They are of particular interest in the fields of neuroscience and neurology, as they have the potential to be used in the treatment of various neurological and neurodegenerative disorders.
